These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 34890866)

  • 21. Survival in rheumatoid arthritis-associated pulmonary arterial hypertension compared with idiopathic pulmonary arterial hypertension.
    Sadeghi S; Granton JT; Akhavan P; Pasarikovski CR; Roos AM; Thenganatt J; Moric J; Johnson SR
    Respirology; 2015 Apr; 20(3):481-7. PubMed ID: 25583377
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Serum N-terminal brain natriuretic peptide as a prognostic parameter in patients with pulmonary hypertension.
    Fijalkowska A; Kurzyna M; Torbicki A; Szewczyk G; Florczyk M; Pruszczyk P; Szturmowicz M
    Chest; 2006 May; 129(5):1313-21. PubMed ID: 16685024
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prognostic role of traditional cardiovascular risk factors in patients with idiopathic pulmonary arterial hypertension.
    Jonas K; Waligóra M; Magoń W; Zdrojewski T; Stokwiszewski J; Płazak W; Podolec P; Kopeć G
    Arch Med Sci; 2019 Oct; 15(6):1397-1406. PubMed ID: 31749867
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Serum PM20D1 levels in patients with idiopathic pulmonary arterial hypertension and its clinical significance.
    Wang L; Liu J; Zhou L; Fu Q
    BMC Cardiovasc Disord; 2024 Apr; 24(1):207. PubMed ID: 38614995
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Exercise pathophysiology differs between connective tissue diseases-associated pulmonary arterial hypertension and idiopathic pulmonary arterial hypertension.
    Zhang Y; Jin Q; Zhao Z; Zhao Q; Yu X; Yan L; Li X; An C; Ma X; Xiong C; Luo Q; Liu Z
    Clin Exp Rheumatol; 2021; 39(5):1063-1070. PubMed ID: 33200733
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluation of pulmonary arterial pressure in patients with connective tissue disease-associated pulmonary arterial hypertension by myocardial perfusion imaging.
    Wang Z; Li J; Wang X; Liu M; Liao M; Zhang C; Shang X
    Ann Noninvasive Electrocardiol; 2022 Mar; 27(2):e12927. PubMed ID: 34908208
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lung neovascularity in pulmonary arterial hypertension associated with congenital heart defects and idiopathic pulmonary arterial hypertension: study of 198 patients.
    Modolon C; Attinà D; Buia F; De Luca F; Fughelli P; Bacchi Reggiani ML; Palazzini M; Manes A; Leci E; Galiè N; Zompatori M
    Eur Radiol; 2012 May; 22(5):1059-66. PubMed ID: 22205444
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Plasma Connective Tissue Growth Factor as a Biomarker of Pulmonary Arterial Hypertension Associated With Congenital Heart Disease in Adults.
    Liu W; Hua Y; Zheng D; Lv W; Zhang W; Chen Q; Huang R; Li X
    Circ J; 2023 Mar; 87(4):527-535. PubMed ID: 36843115
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Circulating markers of inflammation and angiogenesis and clinical outcomes across subtypes of pulmonary arterial hypertension.
    Hirsch K; Nolley S; Ralph DD; Zheng Y; Altemeier WA; Rhodes CJ; Morrell NW; Wilkins MR; Leary PJ; Rayner SG
    J Heart Lung Transplant; 2023 Feb; 42(2):173-182. PubMed ID: 36470771
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Red cell distribution width outperforms other potential circulating biomarkers in predicting survival in idiopathic pulmonary arterial hypertension.
    Rhodes CJ; Wharton J; Howard LS; Gibbs JS; Wilkins MR
    Heart; 2011 Jul; 97(13):1054-60. PubMed ID: 21558476
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pediatric pulmonary hypertension in the Netherlands: epidemiology and characterization during the period 1991 to 2005.
    van Loon RL; Roofthooft MT; Hillege HL; ten Harkel AD; van Osch-Gevers M; Delhaas T; Kapusta L; Strengers JL; Rammeloo L; Clur SA; Mulder BJ; Berger RM
    Circulation; 2011 Oct; 124(16):1755-64. PubMed ID: 21947294
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Nailfold capillaroscopic changes in patients with idiopathic pulmonary arterial hypertension and systemic sclerosis-related pulmonary arterial hypertension.
    Corrado A; Correale M; Mansueto N; Monaco I; Carriero A; Mele A; Colia R; Di Biase M; Cantatore FP
    Microvasc Res; 2017 Nov; 114():46-51. PubMed ID: 28619664
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Blood biomarkers and their potential role in pulmonary arterial hypertension associated with congenital heart disease. a systematic review.
    Giannakoulas G; Mouratoglou SA; Gatzoulis MA; Karvounis H
    Int J Cardiol; 2014 Jul; 174(3):618-23. PubMed ID: 24814894
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Loss of immune homeostasis in patients with idiopathic pulmonary arterial hypertension.
    Heukels P; Corneth OBJ; van Uden D; van Hulst JAC; van den Toorn LM; van den Bosch AE; Wijsenbeek MS; Boomars KA; Kool M; Hendriks RW
    Thorax; 2021 Dec; 76(12):1209-1218. PubMed ID: 33963088
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Differences in Right Ventricular Functional Changes during Treatment between Systemic Sclerosis-associated Pulmonary Arterial Hypertension and Idiopathic Pulmonary Arterial Hypertension.
    Argula RG; Karwa A; Lauer A; Gregg D; Silver RM; Feghali-Bostwick C; Schanpp LM; Egbert K; Usher BW; Ramakrishnan V; Hassoun PM; Strange C
    Ann Am Thorac Soc; 2017 May; 14(5):682-689. PubMed ID: 28282243
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Disproportionate elevation of N-terminal pro-brain natriuretic peptide in scleroderma-related pulmonary hypertension.
    Mathai SC; Bueso M; Hummers LK; Boyce D; Lechtzin N; Le Pavec J; Campo A; Champion HC; Housten T; Forfia PR; Zaiman AL; Wigley FM; Girgis RE; Hassoun PM
    Eur Respir J; 2010 Jan; 35(1):95-104. PubMed ID: 19643943
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Elevated plasma Pim-1 and its clinical significance in patients with pulmonary arterial hypertension.
    Zhu T; Luo J; Wang Y; Xiong X; Sheng B; Yang X; Ndongala NAMT; Li J
    Clin Exp Pharmacol Physiol; 2019 Aug; 46(8):752-760. PubMed ID: 31066078
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Efficacy and Safety of Long-Term Oral Bosentan in Different Types of Pulmonary Arterial Hypertension: A Systematic Review and Meta-Analysis.
    Kuang HY; Li Q; Du HA; Chen M; Yin YH
    Am J Cardiovasc Drugs; 2021 Mar; 21(2):181-191. PubMed ID: 32918210
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Metabolomic Differences in Connective Tissue Disease-Associated Versus Idiopathic Pulmonary Arterial Hypertension in the PVDOMICS Cohort.
    Simpson CE; Hemnes AR; Griffiths M; Grunig G; Tang WHW; Garcia JGN; Barnard J; Comhair SA; Damico RL; Mathai SC; Hassoun PM;
    Arthritis Rheumatol; 2023 Dec; 75(12):2240-2251. PubMed ID: 37335853
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Risk stratification and response to therapy in patients with pulmonary arterial hypertension and comorbidities: A COMPERA analysis.
    Rosenkranz S; Pausch C; Coghlan JG; Huscher D; Pittrow D; Grünig E; Staehler G; Vizza CD; Gall H; Distler O; Delcroix M; Ghofrani HA; Ewert R; Kabitz HJ; Skowasch D; Behr J; Milger K; Halank M; Wilkens H; Seyfarth HJ; Held M; Scelsi L; Neurohr C; Vonk-Noordegraaf A; Ulrich S; Klose H; Claussen M; Eisenmann S; Schmidt KH; Remppis BA; Skride A; Jureviciene E; Gumbiene L; Miliauskas S; Löffler-Ragg J; Lange TJ; Olsson KM; Hoeper MM; Opitz C
    J Heart Lung Transplant; 2023 Jan; 42(1):102-114. PubMed ID: 36333206
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.